His primary areas of investigation include Angiogenesis, Vascular endothelial growth factor, Cell biology, Vascular endothelial growth factor A and Growth factor. His Angiogenesis study combines topics in areas such as Endothelial stem cell, Vasculogenesis and Immunology. His research in Endothelial stem cell intersects with topics in Receptor tyrosine kinase and Fibroblast growth factor.
His Vascular endothelial growth factor research is multidisciplinary, incorporating perspectives in Receptor, Angiopoietin receptor and Glioma. Werner Risau has included themes like Embryonic stem cell, Vascular Endothelial Growth Factor Family and Endothelium in his Cell biology study. The concepts of his Vascular endothelial growth factor A study are interwoven with issues in Endocrinology and Hypoxia.
Werner Risau mainly investigates Cell biology, Angiogenesis, Vascular endothelial growth factor, Vascular endothelial growth factor A and Molecular biology. Werner Risau has researched Cell biology in several fields, including Vasculogenesis, Endothelium, Immunology and Blood–brain barrier. His Angiogenesis research integrates issues from Endothelial stem cell, Growth factor and Fibroblast growth factor.
His Vascular endothelial growth factor study combines topics from a wide range of disciplines, such as Receptor, Endocrinology, Glioma and Pathology. His Vascular endothelial growth factor A research includes elements of Hypoxia and Vascular permeability. His research on Molecular biology also deals with topics like
Werner Risau focuses on Cell biology, Angiogenesis, Vascular endothelial growth factor, Vascular endothelial growth factor A and Molecular biology. His work deals with themes such as Apoptosis, Programmed cell death and Endothelium, which intersect with Cell biology. His Angiogenesis study contributes to a more complete understanding of Cancer research.
The study incorporates disciplines such as Vasculogenesis, Endocrinology and Receptor in addition to Vascular endothelial growth factor. Werner Risau studies Vascular endothelial growth factor C which is a part of Vascular endothelial growth factor A. His research integrates issues of Angioblast and Immunology in his study of Blood vessel.
His primary areas of study are Vascular endothelial growth factor, Angiogenesis, Vascular endothelial growth factor A, Cell biology and Molecular biology. His Vascular endothelial growth factor study frequently draws connections between related disciplines such as Sprouting angiogenesis. His Angiogenesis study combines topics in areas such as Blood vessel, Vascular endothelial growth factor B and Growth factor.
He has researched Vascular endothelial growth factor A in several fields, including Endocrinology and Vascular permeability. His Cell biology study frequently draws connections to adjacent fields such as Gene expression. His Vascular endothelial growth factor C research incorporates themes from Angioblast, Endothelial stem cell, Endothelial cell differentiation and Transgene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mechanisms of angiogenesis
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Peter Carmeliet;Valérie Ferreira;Georg Breier;Saskia Pollefeyt.
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Karl H. Plate;Georg Breier;Herbert A. Weich;Werner Risau.
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.
Birgit Millauer;Susanne Wizigmann-Voos;Harald Schnürch;Ricardo Martinez.
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Thomas N. Sato;Yuzuru Tozawa;Urban Deutsch;Karen Wolburg-Buchholz.
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer B;Shawver Lk;Plate Kh;Risau W.
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
G. Breier;U. Albrecht;S. Sterrer;W. Risau.
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
Matthias Clauss;Herbert Weich;Georg Breier;Ulrike Knies.
Journal of Biological Chemistry (1996)
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
Ralf H. Adams;George A. Wilkinson;Cornelia Weiss;Francesca Diella.
Genes & Development (1999)
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
Marijke Frater-Schroder;Werner Risau;Rupert Hallmann;Peter Gautschi.
Proceedings of the National Academy of Sciences of the United States of America (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: